glp-1 use in type 1 diabetes receptor agonism: a transformative approach for managing type-2 and obesity | Saudi Pharmaceutical Journal GLP-1-based therapies for diabetes, obesity

Melanin is what gives pigment to hair and eyes and colour to the skin

And the benefits aren't just physical they're mental, too

American and European studies report an incidence of 14%-24%, 26,27,28 higher than the 10% incidence found in our study population, which is likely related to patient selection and diagnostic method

Lower scores are better , thus the authors considered this data as potential evidence supporting slowing of disease progression

A study found that kidney afferent nerves stimulate a brain-kidney neural circuit in CKD and heart failure, whichpromotes the SNS to increase disease progression in both organs